Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probenecid in Systolic Heart Failure
NCT01814319Phase 2Completed
- Sponsor
- University of Cincinnati
- Start
- Mar 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial comparing Probenecid First with Placebo First (2 arms). Primary endpoints: 6 Minute Walk Test at 1 week and Shortness of Breath at 1 week. Started Mar 2013; status: completed.
02
Drugs
probenecid
Beyond the preview
Go deeper on NCT01814319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01814319.